These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 16794507)

  • 1. Coexistence of MYCN-activating mutation and amplification in a patient with neuroblastoma.
    Kojima M; Touge R; Kurihara S; Saeki I; Takahashi S; Hiyama E
    Pediatr Blood Cancer; 2024 Aug; 71(8):e31115. PubMed ID: 38773728
    [No Abstract]   [Full Text] [Related]  

  • 2. Multifaceted Roles of ALK Family Receptors and Augmentor Ligands in Health and Disease: A Comprehensive Review.
    Katic L; Priscan A
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome Imbalances in Neuroblastoma-Recent Molecular Insight into Chromosome 1p-deletion, 2p-gain, and 11q-deletion Identifies New Friends and Foes for the Future.
    Guan J; Hallberg B; Palmer RH
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.
    Pezzolo A; Sementa AR; Lerone M; Morini M; Ognibene M; Defferrari R; Mazzocco K; Conte M; Gigliotti AR; Garaventa A; Pistoia V; Varesio L
    Cancer Biol Ther; 2017 May; 18(5):285-289. PubMed ID: 28402723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The WNT-controlled transcriptional regulator LBH is required for mammary stem cell expansion and maintenance of the basal lineage.
    Lindley LE; Curtis KM; Sanchez-Mejias A; Rieger ME; Robbins DJ; Briegel KJ
    Development; 2015 Mar; 142(5):893-904. PubMed ID: 25655704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the significance of germline cytogenetic rearrangements at MYCN locus in neuroblastoma.
    Lipska BS; Koczkowska M; Wierzba J; Ploszynska A; Iliszko M; Izycka-Swieszewska E; Adamkiewicz-Drozynska E; Limon J
    Mol Cytogenet; 2013 Oct; 6(1):43. PubMed ID: 24131700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDM2 as MYCN transcriptional target: implications for neuroblastoma pathogenesis.
    Slack A; Lozano G; Shohet JM
    Cancer Lett; 2005 Oct; 228(1-2):21-7. PubMed ID: 15927364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MYCN oncogene and differentiation in neuroblastoma.
    Westermark UK; Wilhelm M; Frenzel A; Henriksson MA
    Semin Cancer Biol; 2011 Oct; 21(4):256-66. PubMed ID: 21849159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital neuroblastoma in a patient with partial trisomy of 2p.
    Dowa Y; Yamamoto T; Abe Y; Kobayashi M; Hoshino R; Tanaka K; Aida N; Take H; Kato K; Tanaka Y; Ariyama J; Harada N; Matsumoto N; Kurosawa K
    J Pediatr Hematol Oncol; 2006 Jun; 28(6):379-82. PubMed ID: 16794507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metachronous neuroblastoma in an infant with germline translocation resulting in partial trisomy 2p: a role for ALK?
    Morgenstern DA; Soh SY; Stavropoulos DJ; Bowdin S; Baruchel S; Malkin D; Meyn MS; Irwin MS
    J Pediatr Hematol Oncol; 2014 Apr; 36(3):e193-6. PubMed ID: 24276038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroblastoma in a pediatric patient with a microduplication of 2p involving the MYCN locus.
    Van Mater D; Knelson EH; Kaiser-Rogers KA; Armstrong MB
    Am J Med Genet A; 2013 Mar; 161A(3):605-10. PubMed ID: 23401364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics.
    Jeison M; Ash S; Halevy-Berko G; Mardoukh J; Luria D; Avigad S; Feinberg-Gorenshtein G; Goshen Y; Hertzel G; Kapelushnik J; Ben Barak A; Attias D; Steinberg R; Stein J; Stark B; Yaniv I
    Am J Pathol; 2010 Jun; 176(6):2616-25. PubMed ID: 20395439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma.
    Weber A; Imisch P; Bergmann E; Christiansen H
    J Clin Oncol; 2004 Jul; 22(13):2681-90. PubMed ID: 15226335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic and clinical significance of MYCN gain as detected by FISH in neuroblastoma.
    Souzaki R; Tajiri T; Teshiba R; Higashi M; Kinoshita Y; Tanaka S; Taguchi T
    Pediatr Surg Int; 2011 Mar; 27(3):231-6. PubMed ID: 21046119
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.